roflumilast (topical)

Zoryve

Modality

small molecule (topical)

Mechanism

PDE4 inhibitor

Targets

PDE4

Storage

room temperature

Approved

plaque psoriasis — FDA 2022 · seborrheic dermatitis — FDA 2023 · atopic dermatitis — FDA 2024

In trial

—

Sources

Last verified

2026-04-14

No curated MOA diagram yet. See lib/moa-data.ts for the shape; add an entry keyed by roflumilast (topical).